CONTACT
Group Companies
MEDIA STORIES
16-Jun-2020
Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020
06-Jun-2020
Covid provides larger opportunity to shape the biosimilar landscape
19-May-2020
Will invest Rs2,000 crore in small molecules in 3-4 years
16-May-2020
Biocon wins patent case against Sanofi
12-Mar-2020
Biocon’s cancer biosimilar gets US FDA acceptance for review
10-Mar-2020
Biocon chief is EY entrepreneur for 2019
22-Feb-2020
Biocon Biologics Eyes $200M. Plans IPO in 2 Yrs: Mazumdar-Shaw
27-Jan-2020
Biocon Q3 PBT up 9%
24-Jan-2020
Biocon optimistic about hitting $1 billion in revenue by FY22 on back of new launches
08-Jan-2020
Biocon, partner Mylan launch oncology biosimilar trastuzumab in US
11-Dec-2019
USFDA nod to Biocon’s new Bengaluru unit
28-Nov-2019
Biocon, Mylan get nod for pegfilgrastim drug
28-Nov-2019
Indian company makes it to top 10 best employers in biotech category
30-Oct-2019
Insulin at ₹7 will be a gamechanger for us
26-Oct-2019
Life-enabling product like insulin should be made affordable: Shaw
28-Sep-2019
Biocon plans to halve insulin prices
27-Sep-2019
Biocon sets $1 billion target for biologics business
25-Oct-2019
Biocon subsidiary acquires Pfizer’s R&D facility in Chennai
25-Sep-2019
Blueprint for a Healthy India
25-Sep-2019
Ramp-up of biosimilar portfolio to boost Biocon
22-Aug-2019
Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO
30-Jul-2019
Biocon’s net rises 86%, revenue 25%
26-Jul-2019
Biocon net profit grows 72%
25-Jul-2019
Biosimilars, research key drivers for Biocon
18-Jun-2019
Trastuzumab’s US launch will be a big opportunity for Biocon-Mylan: Shaw
18-Jun-2019
Biocon’s Bengaluru biologics units get European agency nod
15-Jun-2019
The First Lady of Biotech
08-Jun-2019
Biocon, Mylan to present data for Ogivri at ASCO meeting
30-May-2019
Canada clears Mylan & Biocon’s Biosimilar
23-May-2019
Biologics to boost Biocon business, say analyst
20-May-2019
Biocon drug gets commercial rights to global markets
09-May-2019
Biosimilars to help Biocon hit $1bn revenue in FY20
30-Apr-2019
Biologics, research services the golden goose for Biocon
27-Apr-2019
Biocon Q4 net profit up 64% to ₹213.7 crore
26-Apr-2019
Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia
18-Apr-2019
Violence,EVM glitches, missing names:Rocky start to election
12-Apr-2019
Research must be promoted in colleges
08-Apr-2019
ET Prime celebrates Women’s Excellence in Business & Innovation
05-Apr-2019
Breakthrough innovation is taking place but we’re not leveraging it
05-Apr-2019
Kiran Mazumdar-Shaw conferred with Honorary Doctorate
04-Apr-2019
Biocon Biologics India appoints Dr. Christiane Hamacher as CEO
01-Apr-2019
Biocon chief stresses on gender equality
29-Mar-2019
Kiran back as Infy’s independent director
19-Mar-2019
Govt Should Scale Up Philanthropic Capital
18-Mar-2019